Anson Funds Management’s MediciNova MNOV Stock Holding History

Anson Funds Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-131,495	Closed	-$352K	–	400
2021 Q4	$352K	Buy	+131,495	New	+$439K	0.03%	267

Other funds holding MNOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's MNOV Position: Q1 2022 in Review

Anson Funds Management sold out of MediciNova (MNOV) in Q1 2022, closing a stake of 131,495 shares — an estimated $352K sold.

Anson Funds Management first reported a position in MNOV in Q4 2021 and held it in 1 quarter. The position peaked at $352K in Q4 2021. 32 funds tracked by Wall St. Rank hold MNOV as of Q1 2022.

Anson Funds Management reported no remaining MediciNova position as of Q1 2022 after selling out during the quarter.
Anson Funds Management sold 131,495 MediciNova shares in Q1 2022, an estimated $352K.
Anson Funds Management first reported a position in MediciNova in Q4 2021 and held it in 1 quarter.
Anson Funds Management's MediciNova position peaked at $352K in Q4 2021.
32 funds tracked by Wall St. Rank held MediciNova as of Q1 2022.

Based on Anson Funds Management's 13F filing for Q1 2022, filed 12 May 2022.